SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001193125-22-176083
Filing Date
2022-06-17
Accepted
2022-06-17 09:10:17
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM F-3 d337128df3a.htm F-3/A 693285
2 EX-23.1 d337128dex231.htm EX-23.1 1881
3 GRAPHIC g337128g00a00.jpg GRAPHIC 118460
4 GRAPHIC g337128g00a04.jpg GRAPHIC 87168
5 GRAPHIC g337128g76n11.jpg GRAPHIC 35544
6 GRAPHIC g337128g82w04.jpg GRAPHIC 33761
  Complete submission text file 0001193125-22-176083.txt   1065477
Mailing Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030
Business Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030 00862164031522
Gracell Biotechnologies Inc. (Filer) CIK: 0001826492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3/A | Act: 33 | File No.: 333-264545 | Film No.: 221022534
SIC: 2834 Pharmaceutical Preparations